IOL Chemicals' ₹495 Cr Mega-Expansion Plan

In a major boost to its long-term growth and business diversification, IOL Chemicals and Pharmaceuticals has announced a ₹495 crore strategic investment across three manufacturing projects. The company will invest ₹350 crore to add 6,000 MTPA of capacity at its flagship Barnala plant in Punjab, scaling total capacity to 18,000 MTPA. In a move toward forward integration into the CDMO segment, IOL is establishing a dedicated facility capable of producing 1,500 million tablets or equivalent Direct Compressible (DC) grade products. Additionally, a ₹35 crore investment will establish a dedicated manufacturing unit under a long-term tolling agreement with a leading global company for a specialty chemical product.

News by Rahul Yelligetti.